In a mouse model of BRCA1/p53-mutated mammary tumor, clonal evolution, resistance to platinum-based chemotherapeutic agents, and enhanced tumor progression was observed in BCSC populations [198]. The gene discussed is BRCA1; the disease is breast cancer.